journal article·2023-09

Long-term antibacterial activity of guanidinium carbon dots without detectable resistance for the effective treatment of pneumonia caused by Gram-negative bacteria

Xintian Zhang, XinXin Bai, Xiaoqin Deng, Kai Peng, Zongfu Zheng, Jiecheng Xiao, Rui Zhang, Zhengjun Huang, Jianyong Huang, Min Chen, Shaohuang Weng

Carbon· Volume 213
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Advanced Drug Delivery Systems · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (89)

Show source-provided references
1. The overlooked pandemic of antimicrobial resistance10.1016/S0140-6736(22)00087-3 ↗
2. Antimicrobial resistance: progress and challenges in antibiotic discovery and anti-infective therapy10.1111/1751-7915.13945 ↗
3. WHO global priority pathogens list on antibiotic resistance: an urgent need for action to integrate One Health data10.1177/1757913917743881 ↗
4. Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections10.2217/fmb-2016-0035 ↗
5. Microwave assisted antibacterial action of Garcinia nanoparticles on Gram-negative bacteria10.1038/s41467-022-30125-w ↗
6. Integrated endotoxin adsorption and antibacterial properties of cationic polyurethane foams for wound healing10.1021/acsami.8b19746 ↗
7. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it10.3390/molecules25061340 ↗
8. The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic10.1183/16000617.0068-2022 ↗
9. Total synthesis of the broad-spectrum antibiotic amycolamicin10.1021/jacs.2c00647 ↗
10. Total synthesis of structurally diverse pleuromutilin antibiotics10.1038/s41557-022-01027-7 ↗
11. Antimicrobial peptides: sustainable application informed by evolutionary constraints10.1016/j.biotechadv.2022.108012 ↗
12. Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY10.1038/s41467-022-35227-z ↗
13. Design and synthesis of phenyl sulfide-based cationic amphiphiles as membrane-targeting antimicrobial agents against gram-positive pathogens10.1021/acs.jmedchem.2c01437 ↗
14. Construction of rhodamine-based AIE photosensitizer hydrogel with clinical potential for selective ablation of drug-resistant gram-positive bacteria in vivo10.1002/adhm.202200837 ↗
15. Identification of 5-(Aryl/Heteroaryl)amino-4-quinolones as potent membrane-disrupting agents to combat antibiotic-resistant gram- positive bacteria10.1021/acs.jmedchem.2c01151 ↗
16. Structure-oriented design strategy to construct NIR AIEgens to selectively combat gram (+) multidrug-resistant bacteria in vivo10.1016/j.biomaterials.2022.121580 ↗
17. Recent progress in multifunctional conjugated polymer nanomaterial- based synergistic combination phototherapy for microbial infection theranostics10.1016/j.ccr.2022.214701 ↗
18. Progress and prospects of nanomaterials against resistant bacteria10.1016/j.jconrel.2022.09.030 ↗
19. Antibacterial applications of elemental nanomaterials10.1016/j.cossms.2022.101043 ↗
20. Biofilm microenvironment-responsive nanoparticles for the treatment of bacterial infection10.1016/j.nantod.2022.101602 ↗
21. Recent nanotechnologies to overcome the bacterial biofilm matrix barriers10.1002/smll.202206220 ↗
22. Carbon dots for killing microorganisms: an update since10.3390/ph15101236 ↗
23. Aminoglycoside-mimicking carbonized polymer dots for bacteremia treatment10.1039/D2NR01959K ↗
24. Carbon dots for intracellular sensing10.1002/sstr.202200033 ↗
25. The light of carbon dots: from mechanism to applications10.1016/j.matt.2021.10.016 ↗
26. Carbon dots in bioimaging, biosensing and therapeutics: a comprehensive review10.1002/smsc.202200012 ↗
27. Carbon dots derived from folic acid as an ultra-succinct smart antimicrobial nanosystem for selective killing of S. aureus and biofilm eradication10.1016/j.carbon.2022.07.065 ↗
28. Copper doped carbon dots for addressing bacterial biofilm formation, wound infection, and tooth staining10.1021/acsnano.2c02518 ↗
29. Nitrogen-doped carbon quantum dots as an antimicrobial agent against Staphylococcus for the treatment of infected wounds10.1016/j.colsurfb.2019.03.042 ↗
30. Quaternized carbon quantum dots with broad-spectrum antibacterial activity for the treatment of wounds infected with mixed bacteria10.1016/j.actbio.2021.11.010 ↗
31. Near-infrared carbon nanodots for effective identification and inactivation of Gram-positive bacteria10.1007/s12274-021-3818-9 ↗
32. Positively charged BODIPY@carbon dot nanocomposites for enhanced photomicrobicidal efficacy and wound healing10.1039/D2TB01539K ↗
33. Selective inactivation of Gram-negative bacteria by carbon dots derived from natural biomass: artemisia argyi leaves10.1039/C9TB02735A ↗
34. Antibacterial properties of citric acid/beta-alanine carbon dots against gram-negative bacteria10.3390/nano11082012 ↗
35. Antibacterial efficiency of carbon dots against Gram-positive and Gram-negative bacteria: a review10.1016/j.jece.2021.106821 ↗
36. Preparation and characterization of B, S, and N-doped glucose carbon dots: antibacterial, antifungal, and antioxidant activity
37. Synthesis of curcumin-quaternized carbon quantum dots with enhanced broad-spectrum antibacterial activity for promoting infected wound healing10.1016/j.msec.2021.112608 ↗
38. Levofloxacin-based carbon dots to enhance antibacterial activities and combat antibiotic resistance10.1016/j.carbon.2021.10.020 ↗
39. Facile access to fabricate carbon dots and perspective of large-scale applications
40. Beyond bottom-up carbon nanodots: citric-acid derived organic molecules10.1016/j.nantod.2015.09.002 ↗
41. Natural and synthetic polymeric antimicrobials with quaternary ammonium moieties: a review10.1007/s10311-021-01215-w ↗
42. Antimicrobial drugs bearing guanidine moieties: a review10.1016/j.ejmech.2021.113293 ↗
43. Antibacterial activity of positively charged carbon quantum dots without detectable resistance for wound healing with mixed bacteria infection10.1016/j.msec.2021.111971 ↗
44. Controllable synthesis and enhanced microwave absorption properities of novel lightweight graphene quantum dots/hexagonal boron nitride composites10.1016/j.carbon.2021.05.064 ↗
45. The quenching of the fluorescence of carbon dots: a review on mechanisms and applications10.1007/s00604-017-2318-9 ↗
46. Super-cationic carbon quantum dots synthesized from spermidine as an eye drop formulation for topical treatment of bacterial keratitis10.1021/acsnano.7b01023 ↗
47. Multi-functional fluorescent carbon dots with antibacterial and gene delivery properties10.1039/C5RA07968C ↗
48. Synthesis and antimicrobial activity of polymeric guanidine and biguanidine salts10.1016/S0032-3861(98)00828-3 ↗
49. Polyurethane-modified graphene oxide composite bilayer wound dressing with long-lasting antibacterial effect10.1016/j.msec.2020.110833 ↗
50. Synthesis, mechanical investigation, and application of nitrogen and phosphorus co-doped carbon dots with a high photoluminescent quantum yield10.1007/s12274-017-1937-0 ↗
51. Surface antimicrobial modification of polyamide by poly(hexamethylene guanidine) hydrochloride10.1002/pat.4911 ↗
52. Polycationic synergistic antibacterial agents with multiple functional components for efficient anti-infective therapy10.1002/adfm.201706709 ↗
53. Photoluminescence-tunable carbon dots from synergy effect of sulfur doping and water engineering10.1016/j.cej.2020.124199 ↗
54. Carbon dots as a potential therapeutic agent for the treatment of cancer-related anemia10.1002/adma.202200905 ↗
55. Tolerance and resistance of microbial biofilms10.1038/s41579-022-00682-4 ↗
56. Biofilm and spore formation of Clostridium perfringens and its resistance to disinfectant and oxidative stress10.3390/antibiotics10040396 ↗
57. Current progress and prospects of organic nanoparticles against bacterial biofilm10.1016/j.cis.2021.102475 ↗
58. Multifunctional quaternized carbon dots with enhanced biofilm penetration and eradication efficiencies10.1039/C9TB00681H ↗
59. Surface modification of carbon dots with tetraalkylammonium moieties for fine tuning their antibacterial activity10.1016/j.msec.2022.112697 ↗
60. Screening of chitosan derivatives-carbon dots based on antibacterial activity and application in anti-Staphylococcus aureus biofilm10.2147/IJN.S350739 ↗
61. Surface chemistry-dependent antibacterial and antibiofilm activities of polyamine-functionalized carbon quantum dots10.1007/s10853-020-05262-6 ↗
62. Based on multi-omics technology study the antibacterial mechanisms of pH-dependent N-GQDs beyond ROS10.1016/j.jhazmat.2022.129954 ↗
63. Screening of chitosan derivatives-carbon dots based on antibacterial activity and application in anti-Staphylococcus aureus biofilm10.2147/IJN.S350739 ↗
64. Antibacterial fluorescent nano-sized lanthanum-doped carbon quantum dot embedded polyvinyl alcohol for accelerated wound healing10.1016/j.jcis.2021.10.018 ↗
65. Injectable self-healing hydrogel fabricated from antibacterial carbon dots and e-polylysine for promoting bacteria-infected wound healing10.1186/s12951-022-01572-w ↗
66. A new antibiotic selectively kills Gram-negative pathogens10.1038/s41586-019-1791-1 ↗
67. Where electrostatics matter: bacterial surface neutralization and membrane disruption by antimicrobial peptides SAAP-148 and OP-14510.3390/biom12091252 ↗
68. Microwave-mediated fabrication of silver nanoparticles incorporated lignin-based composites with enhanced antibacterial activity via electrostatic capture effect10.1016/j.jcis.2020.09.027 ↗
69. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens10.1038/s41564-020-0723-z ↗
70. Lipopolysaccharide endotoxins10.1146/annurev.biochem.71.110601.135414 ↗
71. A signal-on ratiometric fluorometric heparin assay based on the direct interaction between amino-modified carbon dots and DNA10.1007/s00604-018-2798-2 ↗
72. Determination of chondroitin sulfate in synovial fluid and drug by ratiometric fluorescence strategy based on carbon dots quenched FAM-labeled ssDNA10.1016/j.colsurfb.2020.111030 ↗
73. Insight into the DNA adsorption on nitrogen-doped positive carbon dots10.1039/C9RA00881K ↗
74. Fluorescent DNA probing nanoscale MnO(2): adsorption, dissolution by thiol, and nanozyme activity10.1021/acs.langmuir.7b03797 ↗
75. Adsorption of DNA oligonucleotides by boronic acid-functionalized hydrogel nanoparticles10.1021/acs.langmuir.9b01622 ↗
76. Comparison of MoS2, WS2, and graphene oxide for DNA adsorption and sensing10.1021/acs.langmuir.6b04502 ↗
77. Nanomaterials for biosensing lipopolysaccharide10.3390/bios10010002 ↗
78. Comparison of graphene oxide and reduced graphene oxide for DNA adsorption and sensing10.1021/acs.langmuir.6b03032 ↗
79. Adsorption of DNA onto gold nanoparticles and graphene oxide: surface science and applications10.1039/c2cp41186e ↗
80. Desorption of single-stranded nucleic acids from graphene oxide by disruption of hydrogen bonding10.1039/c3an36493c ↗
81. Yttrium oxide as a strongly adsorbing but nonquenching surface for DNA oligonucleotides10.1021/acs.langmuir.9b02743 ↗
82. Dynamic Boolean modelling reveals the influence of energy supply on bacterial efflux pump expression10.1098/rsif.2021.0771 ↗
83. Progress and prospects of nanomaterials against resistant bacteria10.1016/j.jconrel.2022.09.030 ↗
84. Dosage regimen design of intravenous infusion administration of antimicrobial agents
85. Pharmacokinetics, biodistribution, and biosafety of PEGylated gold nanoparticles in vivo10.3390/nano11071702 ↗
86. Material-herbology: an effective and safe strategy to eradicate lethal viral-bacterial pneumonia10.1016/j.matt.2021.07.001 ↗
87. In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles10.1038/s41598-019-48748-3 ↗
88. Causative agents of ventilator-associated pneumonia and resistance to antibiotics in COVID-19 patients: a systematic review10.3390/biomedicines10061226 ↗
89. Diet-induced obesity mice execute pulmonary cell apoptosis via death receptor and ER-stress pathways after E. coli infection